Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis

Author： Rogers Gabriel   Garside Ruth   Mealing Stuart   Pitt Martin   Anderson Rob   Dyer Matthew   Stein Ken   Somerville Margaret  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.1, 2008-01, pp. : 33-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carmustine implants costly in high-grade gliomas

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Antiangiogenic Therapy for High-Grade Gliomas

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 184-194

Bentham Science Publishers

Access to resources Recommend Favorite

Cost-Utility Analysis of Methadone Maintenance Treatment: A Methodological Approach

By Vanagas Giedrius   Padaiga Zilvinas   Bagdonas Eugenijus  

Substance Use & Misuse, Vol. 41, Iss. 1, 2006-06 ,pp. : 87-101

Informa Healthcare

Access to resources Recommend Favorite

Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B

By Dakin Helen   Bentley Anthony   Dusheiko Geoff  

Value in Health, Vol. 13, Iss. 8, 2010-12 ,pp. : 922-933

Blackwell Publishing

Access to resources Recommend Favorite

Carmustine-impregnated wafers and their impact in the management of high-grade glioma

By La Rocca Renato V   Rezazadeh Arash  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1325-1332

Informa Healthcare

Access to resources Recommend Favorite